Predictors of disease activity in 857 patients with MS treated with interferon beta-1b

by Hartung, Hans-Peter, Kappos, Ludwig, Goodin, Douglas S., O’Connor, Paul, Filippi, Massimo, Arnason, Barry, Comi, Giancarlo, Cook, Stuart, Jeffery, Douglas, Petkau, John, White, Richard, Bogumil, Timon, Beckmann, Karola, Stemper, Brigitte, Suarez, Gustavo, Sandbrink, Rupert, Pohl, Christoph
Published 2015

Multi-country real-life experience of anti-vascular endothelial growth factor therapy for wet age-related macular degeneration

by Holz, Frank G, Tadayoni, Ramin, Beatty, Stephen, Berger, Alan, Cereda, Matteo G, Cortez, Rafael, Hoyng, Carel B, Hykin, Philip, Staurenghi, Giovanni, Heldner, Stephanie, Bogumil, Timon, Heah, Theresa, Sivaprasad, Sobha
Published 2015

Incidence and course of depression in multiple sclerosis in the multinational BEYOND trial

by Schippling, Sven, O’Connor, Paul, Knappertz, Volker, Pohl, Christoph, Bogumil, Timon, Suarez, Gustavo, Cook, Stuart, Filippi, Massimo, Hartung, Hans-Peter, Comi, Giancarlo, Jeffery, Douglas R., Kappos, Ludwig, Goodin, Douglas S., Arnason, Barry
Published 2016

Variability in detection and quantification of interferon β-1b–induced neutralizing antibodies

by Hartung, Hans-Peter, Kieseier, Bernd, Goodin, Douglas S, Arnason, Barry GW, Comi, Giancarlo, Cook, Stuart, Filippi, Massimo, Jeffery, Douglas R, Kappos, Ludwig, Bogumil, Timon, Stemper, Brigitte, Sandbrink, Rupert, Nakada, Yukiko, Nakajima, Haruhiko, Schwenke, Susanne, Lehr, Stephan, Heubach, Jürgen, Pohl, Christoph, Reischl, Joachim
Published 2012